For years, the FDA and medical professionals have been clear: a pregnant woman who takes Celexa or similar antidepressants known as selective serotonin reuptake inhibitors (SSRIs) after the 20th week of her pregnancy puts her child at serious risk of a number of birth defects, including persistent pulmonary hypertension (PPHN).
How high is the risk? According to one finding, the probability that a fetus suffers PPHN as a result of the mother’s ingestion of Celexa (citalopram) is 6 times higher than women who do not ingest an SSRI.
How well did drug manufacturers communicate the realities of this risk to physicians, pharmacists, and patients? Not nearly well enough. Some medical professionals believe that Celexa (citalopram) and similar SSRIs are responsible for hundreds – and perhaps thousands – of cases of fetal PPHN. These drugs are dangerous, yet manufacturers failed to fully and completely warn patients of the risks they imposed.
Fears Nachawati protects the victims of Celexa (citalopram) and their families. If you or a loved one have been injured as a result of these dangerous drugs, contact us immediately. We know how to help victims like you, and our experience and expertise puts us in the position to fight for your rights from the negotiating table all the way to the courtroom. For a free consultation, call 1.866.545.8364 or email email@example.com.